Among current molecular targets for advanced non-small cell lung cancer (NSCLC) are c-Ros oncogene 1 (ROS1) and rearranged during transfection (RET), which code for tyrosine kinase receptors. This evidence concerns the gene RET and non-small cell lung carcinoma.